» Articles » PMID: 15926290

Long-term Evaluation of Pulpotomy in Primary Molars Using Mineral Trioxide Aggregate or Formocresol

Overview
Journal Pediatr Dent
Specialty Dentistry
Date 2005 Jun 2
PMID 15926290
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The objective of this study was to assess the effect of mineral trioxide aggregate (MTA) as pulp dressing material following pulpotomy in primary molars with carious pulp exposure and compare them to those of formocresol (FC).

Methods: Of 33 children, primary molars treated via a conventional pulpotomy technique were randomly assigned to the MTA group (33 teeth) or FC group (29 teeth). Clinical and radiographic follow-up ranged between 4 and 74 months. The mean follow-up time was 38 months, with no difference between the groups. Twenty-nine teeth were followed until uneventful shedding (mean=33 months). Failures were detected after a mean period of 16 months (range=4 to 30).

Results: The success rate of pulpotomy was 97% for MTA (1 failure) and 83% for FC (5 failures). Eight teeth presented internal resorption. In 4 of them (2 of each group), progress of the resorption process stopped and the pulp tissue was replaced by a radioopaque calcified tissue. Pulp canal obliteration was observed in 58% of the MTA group and in 52% of the FC group (total=55%).

Conclusions: MTA showed a higher (though not statistically significant) long-term clinical and radiographic success rate than formocresol, and can be recommended as its replacement as, unlike FC, MTA does not induce undesirable responses.

Citing Articles

Clinical and radiographic comparison of primary molar pulpotomy using formocresol, portland cement, and NeoMTA plus: a randomized controlled clinical trial.

Gisour E, Jahanimoghadam F, Karimipour P Sci Rep. 2024; 14(1):29690.

PMID: 39613835 PMC: 11607080. DOI: 10.1038/s41598-024-81180-w.


Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Human Amniotic Membrane Pulpotomy in Primary Molars: A Randomized Clinical Trial.

Joseph E, Rao A, Mahabala K, Shenoy R, Rao A, Srikrishna S Int J Clin Pediatr Dent. 2024; 17(6):641-646.

PMID: 39391137 PMC: 11463797. DOI: 10.5005/jp-journals-10005-2857.


Comparative Evaluation of Amniotic Membrane Derivative, Chitosan with Mineral Trioxide Aggregate, Diode Laser, and Ferric Sulfate as Pulpotomy Agents in Human Primary Molars: An Study.

Lahoti V, Lahoti P, Gundreddy L, Puppala R, Sandeep V, Kethineni B Int J Clin Pediatr Dent. 2024; 17(2):153-157.

PMID: 39184892 PMC: 11339475. DOI: 10.5005/jp-journals-10005-2767.


The Antibacterial Properties of a Reinforced Zinc Oxide Eugenol Combined with Cloisite 5A Nanoclay: An In-Vitro Study.

Nazemisalman B, Niaz S, Darvish S, Notash A, Ramazani A, Luchian I J Funct Biomater. 2024; 15(7).

PMID: 39057319 PMC: 11278227. DOI: 10.3390/jfb15070198.


Treatment outcomes of pulpotomy versus pulpectomy in vital primary molars diagnosed with symptomatic irreversible pulpitis: protocol for a non-inferiority randomised controlled trial.

Philip N, Cherian J, Mathew M, Thomas A, Jodhka S, John N BMC Oral Health. 2024; 24(1):626.

PMID: 38807160 PMC: 11134690. DOI: 10.1186/s12903-024-04411-6.